Susan Tannenbaum, MD and Mansai Shah, MD

University of Connecticut Health Center

The Impact of HER2 Status on the Outcome of Patients with Small Breast Cancers

Awarded $12,000

About the Project: Dr. Tannenbaum and Dr. Shah are hoping to make an impact on patient survival rates by determining how the biology of each specific type of breast cancer affects the outcome on a patient. They will use a database which is already in use at UCONN Health Center to record data on all patients diagnosed with small breast cancers and study their outcomes based on HER2 status. HER2 is a growth factor in breast cancer tumors.